jamescollingse
New member
For their possible use in cancer therapy, repurposed drugs such as ivermectin 12 mg and fenbendazole 222 mg are under research. Early results from animal and laboratory studies indicate these antiparasitic agents may affect cancer cell proliferation, metabolism, and resistance to treatments. Although the findings are interesting, clinical data in humans is still scarce. For use in oncology, these medicines are still unapproved; Their safety in this context has not been shown. Patients should always get professional advice before contemplating such choices; they should never self-medicate. Whether ivermectin and fenbendazole can really help with cancer treatment in the future will be revealed by ongoing trials and research.